papillomavirus

By Targets:	HPV (5) Annexin A (2) Antibiotic (2) Apoptosis (1) Autophagy (5) Bacterial (2) DNA/RNA Synthesis (1) EGFR (1) Filovirus (1) HSV (5) Reverse Transcriptase (1) SARS-CoV (5) Toll-like Receptor (TLR) (5) Virus Protease (2)
By Research Areas:	Cancer (9) Infection (13) Inflammation/Immunology (5)

Targets Recommended: HPV

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-P1907

*Human Papillomavirus* (HPV) E7 protein (49-57)**	HPV	Cancer
Human Papillomavirus (HPV) E7 protein (49-57) is the H-2 ^d-restricted human papillomavirus (HPV) E7_49-57 epitope (short peptide spanning the 49th to 57th amino acid residues in the E7 protein) .

HY-113794

DSHS00884 1 Publications Verification SSYA10-001	Filovirus	Infection
DSHS00884 is a potent *human papillomavirus* E6 inhibitor with an IC₅₀** of 10 μM .

HY-163901

E6-272	HPV Apoptosis	Infection
E6-272 is an inhibitor for *human papillomavirus* 16 (HPV 16). E6-272 inhibits the proliferation of HPV-positive cells SiHa and CaSki with GI₅₀ of 32 nM and 62 nM. E6-272 induces apoptosis** in cell SiHa and CaSki .

HY-136466

A2ti-2 1 Publications Verification	Annexin A Virus Protease HPV	Infection
A2ti-2 is a selective and low-affinity annexin A2/S100A10 heterotetramer (A2t) inhibitor with an IC₅₀ of 230 μM . A2ti-2 specifically disrupts the protein-protein interaction (PPI) between A2 and S100A10. A2ti-2 prevents human papillomavirus type 16 (HPV16) infection .

HY-136465

A2ti-1 2 Publications Verification	Annexin A Virus Protease HPV	Infection
A2ti-1 is a selective and high-affinity annexin A2/S100A10 heterotetramer (A2t) inhibitor with an IC₅₀ of 24 μM . A2ti-1 specifically disrupts the protein-protein interaction (PPI) between A2 and S100A10. A2ti-1 prevents human papillomavirus type 16 (HPV16) infection .

HY-15336

AG 555 Tyrphostin AG 555	EGFR Reverse Transcriptase	Cancer
AG 555 (Tyrphostin AG 555), a potent antiretroviral agent, is a potent and selective inhibitor of EGFR and blocks Cdk2 activation .

HY-P991215

Anti-HPV18 L1 Antibody (H18L1-A)	HPV	Infection
Anti-HPV18 L1 Antibody (H18L1-A) is a humanized antibody targeting the L1 protein of human papillomavirus type 18 (HPV18). Anti-HPV18 L1 Antibody (H18L1-A) blocks the binding of the HPV18 virus to cell surface receptors, neutralizing the virus activity, and thus inhibiting the virus from infecting cells. Anti-HPV18 L1 Antibody (H18L1-A) is promising for research of human papillomavirus-related diseases .

HY-N14752

Hydroxymycotrienin A	Antibiotic Bacterial	Infection Cancer
Hydroxymycotrienin A is an Ansa antibiotic. Hydroxymycotrienin A has the activity of inhibiting human neck tumor cell line, and its inhibitory effect on human papillomavirus (HPV) gene positive neck tumor cells (such as HeLa, CaSK_i, SiHa, etc.) is stronger than HPV gene negative cells .

HY-N15103

Hydroxymycotrienin B	Antibiotic Bacterial	Infection Cancer
Hydroxymycotrienin B is an Ansa antibiotic. Hydroxymycotrienin B has the activity of inhibiting human neck tumor cell line, and its inhibitory effect on human papillomavirus (HPV) gene positive neck tumor cells (such as HeLa, CaSK_i, SiHa, etc.) is stronger than HPV gene negative cells .

HY-164018A

PMEG-DP disodium	DNA/RNA Synthesis	Infection
PMEG-DP disodium is a potent DNA polymerase inhibitor (IC₅₀=2.5 μM), especially for DNA polymerase α and δ. PMEG-DP disodium acts as an active metabolite of G-9191, which effectively inhibits the growth of papillomavirus (HPV) -infected cell lines. PMEG-DP disodium can be used in the study of HPV-related diseases .

HY-B0180C

Imiquimod dihydrochloride R 837 dihydrochloride	Toll-like Receptor (TLR) Autophagy SARS-CoV HSV	Infection Inflammation/Immunology Cancer
Imiquimod (R 837) dihydrochloride, an immune response modifier, is a selective toll like receptor 7 (TLR7) agonist. Imiquimod exhibits antiviral and antitumor effects in vivo. Imiquimod can be used for the research of external genital, perianal warts, cancer and COVID-19 .

HY-B0180

Imiquimod Maximum Cited Publications 43 Publications Verification R 837	Toll-like Receptor (TLR) Autophagy SARS-CoV HSV	Infection Inflammation/Immunology Cancer
Imiquimod (R 837), an immune response modifier, is a selective toll like receptor 7 (TLR7) agonist. Imiquimod exhibits antiviral and antitumor effects in vivo. Imiquimod can be used for the research of external genital, perianal warts, cancer and COVID-19 .

HY-B0180R

Imiquimod (Standard)	Toll-like Receptor (TLR) Autophagy SARS-CoV HSV	Infection Inflammation/Immunology Cancer
Imiquimod (Standard) is the analytical standard of Imiquimod. This product is intended for research and analytical applications. Imiquimod (R 837), an immune response modifier, is a selective toll like receptor 7 (TLR7) agonist. Imiquimod exhibits antiviral and antitumor effects in vivo. Imiquimod can be used for the research of external genital, perianal warts, cancer and COVID-19 .

HY-B0180A

Imiquimod hydrochloride Maximum Cited Publications 43 Publications Verification R 837 hydrochloride	Toll-like Receptor (TLR) Autophagy SARS-CoV HSV	Infection Inflammation/Immunology Cancer
Imiquimod hydrochloride (R 837 hydrochloride), an immune response modifier, is a selective toll like receptor 7 (TLR7) agonist. Imiquimod hydrochloride exhibits antiviral and antitumor effects in vivo. Imiquimod hydrochloride can be used for the research of external genital, perianal warts, cancer and COVID-19 .

HY-B0180B

Imiquimod maleate Maximum Cited Publications 43 Publications Verification R 837 maleate	Toll-like Receptor (TLR) Autophagy SARS-CoV HSV	Infection Inflammation/Immunology Cancer
Imiquimod maleate (R 837 maleate), an immune response modifier, is a selective toll like receptor 7 (TLR7) agonist. Imiquimod maleate exhibits antiviral and antitumor effects in vivo. Imiquimod maleate can be used for the research of external genital, perianal warts, cancer and COVID-19 .

Cat. No.	Product Name	Target	Research Area

HY-P1907

*Human Papillomavirus* (HPV) E7 protein (49-57)**	HPV	Cancer
Human Papillomavirus (HPV) E7 protein (49-57) is the H-2 ^d-restricted human papillomavirus (HPV) E7_49-57 epitope (short peptide spanning the 49th to 57th amino acid residues in the E7 protein) .

Cat. No.	Product Name	Target	Research Area

HY-P991215

Anti-HPV18 L1 Antibody (H18L1-A)	HPV	Infection
Anti-HPV18 L1 Antibody (H18L1-A) is a humanized antibody targeting the L1 protein of human papillomavirus type 18 (HPV18). Anti-HPV18 L1 Antibody (H18L1-A) blocks the binding of the HPV18 virus to cell surface receptors, neutralizing the virus activity, and thus inhibiting the virus from infecting cells. Anti-HPV18 L1 Antibody (H18L1-A) is promising for research of human papillomavirus-related diseases .

Cat. No.	Product Name	Category	Target	Chemical Structure

HY-N14752

Hydroxymycotrienin A	Structural Classification Microorganisms Antibiotics Source classification Other Antibiotics	Antibiotic Bacterial
Hydroxymycotrienin A is an Ansa antibiotic. Hydroxymycotrienin A has the activity of inhibiting human neck tumor cell line, and its inhibitory effect on human papillomavirus (HPV) gene positive neck tumor cells (such as HeLa, CaSK_i, SiHa, etc.) is stronger than HPV gene negative cells .

HY-N15103

Hydroxymycotrienin B	Structural Classification Natural Products Microorganisms Source classification	Antibiotic Bacterial
Hydroxymycotrienin B is an Ansa antibiotic. Hydroxymycotrienin B has the activity of inhibiting human neck tumor cell line, and its inhibitory effect on human papillomavirus (HPV) gene positive neck tumor cells (such as HeLa, CaSK_i, SiHa, etc.) is stronger than HPV gene negative cells .

Species:	Human (2)
Tag:	His (1) Tag Free (1) Strep (1)
Source:	E. coli (2)

Cat. No.	Compare	Product Name	Species	Source

HY-P701866

	TRIP13 Protein, Human TRIP13; Pachytene checkpoint protein 2 homolog; Human papillomavirus type 16 E1 protein-binding protein; 16E1-BP; HPV16 E1 protein-binding protein; Thyroid hormone receptor interactor 13; Thyroid receptor-interacting protein 13; TR-interacting protein 13; TRIP-13	Human	E. coli
	The TRIP13 protein plays a key role in meiosis, affecting chromosome reorganization and structural development. It is critical for the formation of crossing and noncrossing pathways, homologous synapses, and synaptonemal complexes. TRIP13 Protein, Human is the recombinant human-derived TRIP13 protein, expressed by E. coli , with tag free.

HY-P701865

	TRIP13 Protein, Human (His, StrepⅡ) TRIP13; Pachytene checkpoint protein 2 homolog; Human papillomavirus type 16 E1 protein-binding protein; 16E1-BP; HPV16 E1 protein-binding protein; Thyroid hormone receptor interactor 13; Thyroid receptor-interacting protein 13; TR-interacting protein 13; TRIP-13	Human	E. coli
	The TRIP13 protein plays a key role in meiosis, affecting chromosome reorganization and structural development. It is critical for the formation of crossing and noncrossing pathways, homologous synapses, and synaptonemal complexes. TRIP13 Protein, Human (His, Strep) is the recombinant human-derived TRIP13 protein, expressed by E. coli , with N-Strep, N-6*His labeled tag.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inhibitors & Agonists

Peptides

Inhibitory Antibodies

Natural
Products

Recombinant Proteins

Name
Email *

	Sorry, but the email address you supplied was invalid.

papillomavirus

Inhibitors & Agonists

Peptides

Inhibitory Antibodies

NaturalProducts

Recombinant Proteins

Natural
Products